← Open Payments lookup

MEGAN SKRADIS: Open Payments

NPI 1750911020 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$557 in 25 payments from 12 companies in 2025. Trend: 2023 $669 · 2024 $462 · 2025 $557

Food & beverage: $557
CompanyPaymentsAmount
Phathom Pharmaceuticals, Inc.6$176
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$82
ABBVIE INC.3$68
PFIZER INC.3$66
Smith+Nephew, Inc.1$31
Otsuka America Pharmaceutical, Inc.2$28
Azurity Pharmaceuticals, Inc.1$24
Merck Sharp & Dohme LLC1$22
Sumitomo Pharma America, Inc.1$16
Novo Nordisk Inc1$15

Products named: VOQUEZNA, CAPLYTA, PAXLOVID, QULIPTA, COLLAGENASE SANTYL, REXULTI, VRAYLAR, AZMIRO.

Industry payments across NE — which companies pay providers there.